New eye drug AVT29 takes on eylea HD in major trial
Disease control
Recruiting now
This study tests a new medicine called AVT29 against an existing drug, Eylea HD, for people with diabetic macular edema (DME), a condition that causes vision loss in people with diabetes. About 256 adults will receive either AVT29 or Eylea HD to see if AVT29 works just as well at…
Phase: PHASE3 • Sponsor: Alvotech Swiss AG • Aim: Disease control
Last updated May 15, 2026 11:56 UTC